参考文献/References:
[1]国家心血管病中心,中国心血管健康与疾病报告编写组,胡盛寿. 中国心血管健康与疾病报告2023概要[J].中国循环杂志,2024,39(7):625-660.[2]Galve E,Garcia-Del-Castillo H,Evangelista A,et al. Pericardial effusion in the course of myocardial infarction: incidence,natural history,and clinical relevance[J]. Circulation,1986,73(2):294-299.
[3]Gündüz R,Y?d? BS,?tin N,et al. Multi-Center Experience of Coronary Artery Perforation During Percutaneous Coronary Intervention: Clinical and angiographic characteristics,management,and outcomes between 2010 and 2020[J]. Anatol J Cardiol,2022,26(8):608-618.?/div>
[4]苏长阳,王明生,王磊,等.急性前壁心肌梗死早期合并少量心包积液致心脏压塞并文献复习[J].中国医药导刊,2013,15(7):1133-1134.
[5]Jobs A,Eitel C,P?s J,et al.Effect of pericardial effusion complicating ST-elevation myocardial infarction as predictor of extensive myocardial damage and prognosis[J]. Am J Cardiol,2015,116(7):1010-1016.
[6]Basso C,Rizzo S,Thiene G. The metamorphosis of myocardial infarction following coronary recanalization[J]. Cardiovasc Pathol,2010,19(1):22-28.?/div>
[7]Wang X,Yang G,Li J,et al. Dynamic molecular signatures of acute myocardial infarction based on transcriptomics and metabolomics[J]. Sci Rep,2024,14(1):10175.?/div>
[8]Lu Q,Liu P,Huo JH,et al.Correction to: Cardiac rupture complicating acute myocardial infarction: the clinical features from an observational study and animal experiment [J]. BMC Cardiovasc Disord,2020,20(1):441.
[9]李建辉,魏璇,鲍雪,等.急性ST段抬高型心肌梗死介入术后心肌内出血的相关因素分析[J]. 中国动脉硬化杂志,2021,29(2):135-142.
[10]Denicolai M,Morello M,Del Buono MG,et al. Cardiac rupture as a life-threatening outcome of Takotsubo syndrome: A systematic review[J]. Int J Cardiol,2024,412:132336.?/div>
[11]Zeng S,Zheng Y,Jiang J,et al. Effectiveness and safety of DOACs vs. warfarin in patients with atrial fibrillation and frailty: a systematic review and meta-analysis[J]. Front Cardiovasc Med,2022,9:907197.
[12]王凯阳,刘凤双,刘永国,等. 代谢综合征及各组分与急性心肌梗死患者冠状动脉病变程度及临床结局的相关性研究[J]. 中华全科医学,2024,22(2):212-216,239.
[13]Figueras J,Juncal A,Carballo J,et al. Nature and progression of pericardial effusion in patients with a first myocardial infarction: relationship to age and free wall rupture[J]. Am Heart J,2002,144(2):251-258.?/div>
[14]林丽容,卢荔红,黄鼎三,等.急性心肌梗死患者并发心包积液的影响因素分析[J].福建医药杂志,2020,42(4):27-29.
[15]Heger LA,Schommer N,van Bruggen S,et al. Neutrophil NLRP3 promotes cardiac injury following acute myocardial infarction through IL-1β production,VWF release and NET deposition in the myocardium[J]. Sci Rep,2024,14(1):14524.
[16]Griesenauer B,Paczesny S. The ST2/IL-33 axis in immune cells during inflammatory diseases[J]. Front Immunol,2017,8:475.?/div>
[17]Duan T,Du Y,Xing C,et al. Toll-like receptor signaling and its role in cell-mediated immunity[J]. Front Immunol,2022,13:812774.?/div>
[18]Jiang H,Yang J,Li T,et al.JAK/STAT3 signaling in cardiac fibrosis: a promising therapeutic target[J]. Front Pharmacol,2024,15:1336102.?/div>
[19]Saadat S,Noureddini M,Mahjoubin-Tehran M,et al.Pivotal role of TGF-β/Smad signaling in cardiac fibrosis: non-coding RNAs as effectual players[J]. Front Cardiovasc Med,2021,7:588347.?/div>
[20]Hanna A,Humeres C,Frangogiannis NG. The role of Smad signaling cascades in cardiac fibrosis[J]. Cell Signal,2021,77:109826.?/div>
[21]Santos-Zas I,Lemarié J,Tedgui A,et al. Adaptive immune responses contribute to post-ischemic cardiac remodeling[J]. Front Cardiovasc Med,2019,5:198.
[22]Wang J,Han B. Dysregulated CD4+ T cells and microRNAs in myocarditis[J]. Front Immunol,2020,11:539.?/div>
[23]Bansal SS,Ismahil MA,Goel M,et al. Activated T lymphocytes are essential drivers of pathological remodeling in ischemic heart failure[J]. Circ Heart Fail,2017,10(3):e003688.?/div>
[24]Liu J,Liu F,Liang T,et al.The roles of Th cells in myocardial infarction[J]. Cell Death Discov,2024,10(1):287.
[25]Ebrahimi P,Taheri H,Bahiraie P,et al. Incidence of secondary pericardial effusions associated with different etiologies: a comprehensive review of literature [J]. J Cardiothorac Surg,2025,20(1):141.?/div>
[26]Pepe M,Addabbo F,Cecere A,Tritto R,et al.Acute hyperglycemia-induced injury in myocardial infarction[J]. Int J Mol Sci,2024,25(15):8504.
[27]曹树军,许振业,汤玮,等.糖化血红蛋白水平对急性心肌梗死合并糖尿病患者冠状动脉病变程度的影响[J].中国分子心脏病学杂志,2024,24(4):6220-6225.?/div>
[28]Paolisso P,Foà A,Bergamaschi L,et al. Hyperglycemia,inflammatory response and infarct size in obstructive acute myocardial infarction and MINOCA[J]. Cardiovasc Diabetol,2021,20(1):33.
[29]Li Y,Liu Y,Liu S,et al. Diabetic vascular diseases: molecular mechanisms and therapeutic strategies. Signal transduct target ther[J]. 2023 Apr 10;8(1):152.?/div>
[30]Horton WB,Barrett EJ. Microvascular Dysfunction in diabetes mellitus and cardiometabolic disease[J]. Endocr Rev,2021,42(1):29-55.?/div>
[31]Mo B,Ding Y,Ji Q. NLRP3 inflammasome in cardiovascular diseases: an update[J]. Front Immunol,2025,16:1550226.?/div>
[32]Lang RM,?adano LP,?or-Avi V,et al.Recommendations for cardiac chamber quantification by echocardiography in adults:an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging[J]. J Am Soc Echocardiogr,2015,28(1):1-39.e14.
[33]Byrne RA,Rossello X,Coughlan JJ,et al. ESC scientific document group,2023 ESC guidelines for the management of acute coronary syndromes[J]. Eur Heart J,2023,44(38):3720-3826.
[34]贾海波,何路平,徐艺硕,等.《光学相干断层成像技术在冠心病介入诊疗中应用的中国专家共识》解读[J].临床心血管病杂志,2023,39(3):167-171.
[35]Chen Y,Ren D,Guan X,et al. Correction to: quantification of myocardial hemorrhage using T2* cardiovascular magnetic resonance at 1.5 T with ex-vivo validation[J]. J Cardiovasc Magn Reson,2022,24(1):11.?/div>
[36]Ji H,Yuan L,Jiang W,et al. Long-term prognostic importance of high levels of sST2 in patient with AMI: a meta-analysis[J]. Am J Transl Res,2024,16(1):1-11.?/div>
[37]Collini V,de Martino M,Andreis A,et al. Efficacy and safety of colchicine for the treatment of myopericarditis[J]. Heart,2024,110(10):735-739.?/div>
[38]Foglio E,Pellegrini L,Russo MA,et al. HMGB1-mediated activation of the inflammatory-reparative response following myocardial infarction[J]. Cells,2022,11(2):216.?/div>
[39]Date S,Bhatt LK. Targeting high-mobility-group-box-1-mediated inflammation: a promising therapeutic approach for myocardial infarction[J]. Inflammopharmacology,2025 Feb;33(2):767-784.
[40]Astiawati T,Rohman MS,Wihastuti T,et al. The emerging role of colchicine to inhibit NOD-like receptor family,pyrin domain containing 3 inflammasome and interleukin-1β expression in in vitro models[J]. Biomolecules,2025,15(3):367.?/div>
[41]Toldo S,Mezzaroma E,Buckley LF,et al. Targeting the NLRP3 inflammasome in cardiovascular diseases[J]. Pharmacol Ther,2022,236:108053.
相似文献/References:
[1]林远龙,刘现亮.无复流现象:从基础到临床[J].心血管病学进展,2016,(1):53.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.014]
LIN Yuanlong,LIU Xianliang.From Bench to Bed:No-reflow Phenomenon[J].Advances in Cardiovascular Diseases,2016,(12):53.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.014]
[2]赵劲东,综述,董平栓,等.合并多支血管病变的急性ST段抬高型心肌梗死介入术治疗策略的研究进展[J].心血管病学进展,2016,(3):295.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.021]
ZHAO Jindong,DONG Pingshuan.Research Progress of Interventional Therapy in Patients with ST-elevation
Myocardial Infarction and Multivessel Disease[J].Advances in Cardiovascular Diseases,2016,(12):295.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.021]
[3]余正春,综述,马小静,等.急性心肌梗死并发心源性休克的治疗进展[J].心血管病学进展,2016,(4):441.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.029]
YU Zhengchun,MA Xiaojing.Treatment of Cardiogenic Shock Complicating Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2016,(12):441.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.029]
[4]袁帅,毛玉琳,钱志敏,等.经皮冠脉介入术在高龄老年患者治疗中的研究新进展[J].心血管病学进展,2019,(6):864.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.007]
YUAN Shuai,MAO Yulin,QIAN Zhimin,et al.New Progress in Study of PCI in treatment of Elderly Patients[J].Advances in Cardiovascular Diseases,2019,(12):864.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.007]
[5]元洋洋 李波.Selvester QRS评分系统研究进展[J].心血管病学进展,2019,(7):985.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.005]
YUAN YangyangLI Bo.Research Progress of Selvester QRS Scoring System[J].Advances in Cardiovascular Diseases,2019,(12):985.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.005]
[6]翁子骞 于波.血栓抽吸在急性ST段抬高型心肌梗死中的研究进展[J].心血管病学进展,2019,(7):1035.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.018]
WENG ZiqianYU Bo.Thrombus aspiration in acute ST-segment elevation myocardial infarction[J].Advances in Cardiovascular Diseases,2019,(12):1035.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.018]
[7]林莉 韦铁民.急性心肌梗死后心脏破裂[J].心血管病学进展,2019,(7):1039.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.019]
LIN LiWEI Tiemin.Post-infarction Cardiac Rupture[J].Advances in Cardiovascular Diseases,2019,(12):1039.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.019]
[8]杨颜瑜,苏星,谭敏,等.炎症指标与急性心肌梗死研究进展[J].心血管病学进展,2019,(6):947.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.027]
YANG Yanyu,SU Xing,TAN Min,et al.Relationship Between Inflammation Index and Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(12):947.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.027]
[9]崔小豪 杨志明.和肽素在急性心肌梗死中的研究进展[J].心血管病学进展,2019,(5):726.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.016]
CUI Xiaohao,YANG Zhiming.Copeptin in Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(12):726.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.016]
[10]潘甜 马康华.急性心肌梗死经皮冠脉介入术后冠状动脉无复流的预防和治疗进展[J].心血管病学进展,2019,(5):730.[doi:10.16806/j.cnki.issn.1004-3932019.05.017]
PAN Tian,MA Kanghua.Prevention and Treatment of Coronary Artery No-Reflow after Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(12):730.[doi:10.16806/j.cnki.issn.1004-3932019.05.017]